First, we established a patient-derived xenograft (PDX) model to implant subcutaneously tumor cells dissected from an adenocarcinoma patient into immunodeficient NOD/scid/IL2rγ−/− (NSG) mice. The gene discussed is IL2RG; the disease is adenocarcinoma.